Cytarabine (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Cytarabine drug offered from Fresenius Kabi USA, LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | CYTARABINE |
| SUBSTANCE NAME: | CYTARABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2004-11-29 |
| END MARKETING DATE: | 0000-00-00 |
Cytarabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cytarabine from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 2004-11-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-120_6594799a-7b02-4847-aff7-1cb7842771bd |
| PRODUCT NDC: | 63323-120 |
| APPLICATION NUMBER: | ANDA076512 |
Other CYTARABINE Pharmaceutical Manufacturers / Labelers:
